Obagi Medical Gets Higher Offer from Merz Pharma

02.04.2013 - Neurological and dermatology drugs maker Merz Pharma offered to buy cosmetic products maker Obagi Medical Products for $383.5 million, topping a bid by Canada's Valeant...